SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
amyloid
Journals
16
1
Redox biology
2
European journal of nuclear medicine and molecular imaging
3
computational and structural biotechnology journal
4
the journal of pathology
5
journal of biological inorganic chemistry : jbic : a publication of the society of biological inorganic chemistry
6
neurobiology of aging
7
IEEE Transactions on Neural Networks and Learning Systems
8
scandinavian journal of work, environment & health
9
advances in protein chemistry and structural biology
10
European journal of neurology
11
journal of nephrology
12
Alzheimer's & dementia : the journal of the Alzheimer's Association
13
child development
14
Clinical nuclear medicine
15
The journal of prevention of Alzheimer's disease
16
journal of the american society of cytopathology
Research Groups
0
No Research Group Connected
Bibliographies
247
1
Cerebrospinal fluid amyloid levels are associated with delayed memory retention in cognitively normal biomarker-negative older adults.
2
Metal coordination and peripheral substitution modulate the activity of cyclic tetrapyrroles on αS aggregation: a structural and cell-based study.
3
Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease.
4
Energy Disaggregation via Deep Temporal Dictionary Learning.
5
Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD.
6
Young Children's Mathematical Learning From Intelligent Characters.
7
Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters.
8
Functional and dysfunctional folding, association and aggregation of caseins.
9
Cisd2: A promising new target in Alzheimer's disease.
10
Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy.
11
Cytodiagnosis and protein typing of amyloid from a vitreous washing: initial diagnostic workup of hereditary amyloidosis.
12
Phosphorylated cofilin-2 is more prone to oxidative modifications on Cys39 and favors amyloid fibril formation.
13
influence of the aqueous environment on protein structure—a plausible hypothesis concerning the mechanism of amyloidogenesis
14
polymorphism of amyloid-like fibrils can be defined by the concentration of seeds
15
opinion: an evaluation of progressive amyloidogenic and pro-inflammatory change in the primary visual cortex and retina in alzheimer’s disease (ad)
16
differential contributions of apoe4 and female sex to bace1 activity and expression mediate aβ deposition and learning and memory in mouse models of alzheimer’s disease
17
neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for cte
18
computational analysis of candidate prion-like proteins in bacteria and their role
19
protein folding activity of the ribosome (pfar) –– a target for antiprion compounds
20
smoking and progression of alzheimers disease: connecting edges
21
a complex relationship between suicide, dementia, and amyloid: a narrative review
22
modelling alzheimer’s disease: from past to future
23
Difference in trajectories according to early amyloid accumulation in cognitively unimpaired elderly.
24
Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment.
25
Longitudinal Trajectories of the Cognitive Function Index in the A4 Study.
26
Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.
27
A Peculiar Tau Accumulation Pattern Identified Via 18 F-Florzolotau PET Imaging in a Patient With Frontotemporal Dementia Caused by a Mutation in the MAPT Gene.
28
A deep learning model for generating [F]FDG PET Images from early-phase [F]Florbetapir and [F]Flutemetamol PET images.
29
Effective Theranostic Cyanine for Imaging of Amyloid Species in Vivo and Cognitive Improvements in Mouse Model.
30
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.
31
Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells.
32
Functionalized gold and silver nanoparticles modulate amyloid fibrillation, defibrillation and cytotoxicity of lysozyme via altering protein surface character
33
Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
34
Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42.
35
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.
36
Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells.
37
Discovery of N-methylpiperazinyl flavones as a novel class of compounds with therapeutic potential against Alzheimer's disease: Synthesis, binding affinity towards amyloid β oligomers (Aβo) and ability to disrupt Aβo-PrP <sup>C</sup> interactions
38
Guiding the Morphology of Amyloid Assemblies by Electrostatic Capping: from Polymorphic Twisted Fibrils to Uniform Nanorods.
39
PDB_Amyloid: an extended live amyloid structure list from the PDB.
40
Intestinal Serum amyloid A suppresses systemic neutrophil activation and bactericidal activity in response to microbiota colonization.
41
Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage
42
Predictors for Late Post-Intracerebral Hemorrhage Dementia in Patients with Probable Cerebral Amyloid Angiopathy.
43
Shear-induced amyloid formation of IDPs in the brain
44
Amiloidose e insuficiência renal crônica terminal associada à hanseníase Amyloidosis and end-stage renal disease associated with leprosy
45
[The plasma level of amyloid-β is associated with cognitive decline: a two years follow-up study in Xi'an rural areas].
46
Neurite orientation dispersion and density imaging reveals white matter and hippocampal microstructure changes produced by Interleukin-6 in the TgCRND8 mouse model of amyloidosis.
47
Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.
48
Synaptic and memory dysfunction in a β-amyloid model of early Alzheimer's disease depends on increased formation of ATP-derived extracellular adenosine
49
The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease
50
Characteristics and natural history of autonomic involvement in hereditary ATTR amyloidosis: a systematic review.
51
Recent Insights in Islet Amyloid Polypeptide-Induced Membrane Disruption and Its Role in β-Cell Death in Type 2 Diabetes Mellitus
52
Frictional amyloidosis in Oman - A study of ten cases
53
High internal phase emulsions stabilized with amyloid fibrils and their polysaccharide complexes for encapsulation and protection of β-carotene.
54
Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis.
55
Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis.
56
Quantitative Tc-DPD SPECT/CT in patients with suspected ATTR cardiac amyloidosis: Feasibility and correlation with visual scores.
57
Concerning a clue on the enigma of "amyloid made" versus "amyloid regulated" channels in cell membranes: A comment on M. A. Mukhamedyarov et al., Neuroscience and behavioral physiology, Vol. 43, No. 4, pp. 479-484 (2013)
58
[Comparison analysis of outcomes in primary light chain amyloidosis patients treated by auto peripheral blood stem cell transplantation or bortezomib plus dexamethasone].
59
Promotion Effect of Succinimide on Amyloid Fibrillation of Hen Egg-White Lysozyme.
60
Genetic Logic Gates Enable Patterning of Amyloid Nanofibers.
61
Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid β Toxicity: Relevance to Alzheimer's Disease.
62
Therapeutic effects of Cyperus rotundus rhizome extract on memory impairment, neurogenesis and mitochondria in beta-amyloid rat model of Alzheimer's disease.
63
Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa.
64
A new purified Lawsoniaside remodels amyloid-β fibrillation into a less toxic and non-amyloidogenic pathway.
65
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals
66
Association of Intracranial Atherosclerotic Disease With Brain β-Amyloid Deposition: Secondary Analysis of the ARIC Study.
67
Mercury and Alzheimer's Disease: Hg(II) Ions Display Specific Binding to the Amyloid-β Peptide and Hinder Its Fibrillization.
68
A Rare Case of Hoarseness: Laryngeal Amyloidosis
69
Inferring Mechanistic Parameters from Amyloid Formation Kinetics by Approximate Bayesian Computation.
70
Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS)
71
Recurrent pericardial effusion with pericardial amyloid deposition: a case report and literature review
72
Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.
73
Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease.
74
"Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease.
75
Selected microRNAs Increase Synaptic Resilience to the Damaging Binding of the Alzheimer's Disease Amyloid Beta Oligomers.
76
Metal Ion Binding to the Amyloid β Monomer Studied by Native Top-Down FTICR Mass Spectrometry.
77
[Treatment strategies of patients with transthyretin amyloidosis cardiomyopathy].
78
Strategies Targeting Soluble β-Amyloid Oligomers and their Application to Early Diagnosis of Alzheimer's Disease.
79
Serum Amyloid A is Expressed in the Brain After Traumatic Brain Injury in a Sex-Dependent Manner.
80
Microglial responses after phagocytosis: Escherichia coli bioparticles, but not cell debris or amyloid beta, induce matrix metalloproteinase-9 secretion in cultured rat primary microglial cells.
81
CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells
82
Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ
83
Association between serum amyloid A levels and coronary heart disease: a systematic review and meta-analysis of 26 studies.
84
Utility of serum amyloid A as a potential prognostic biomarker of acute primary basal ganglia hemorrhage.
85
High-Density Lipoprotein (HDL) Inhibits Serum Amyloid A (SAA)-Induced Vascular and Renal Dysfunctions in Apolipoprotein E-Deficient Mice.
86
Metal-dependent inhibition of amyloid fibril formation: synergistic effects of cobalt-tannic acid networks.
87
The Challenges in Chemotherapy and Stem Cell Transplantation for Light-Chain Amyloidosis.
88
Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations.
89
Decrease in 130 kDa- amyloid protein precursor protein (app) and APP protein ratio in schizophrenia platelets.
90
Retraction notice to "Peptide-induced formation of protein aggregates and amyloid fibrils in human and Guinea pig αA-crystallins under physiological conditions of temperature and pH" [Exp. Eye Res. 179 (2019) 193-205].
91
Migration of perivascular cells into the neuropil and their involvement in β-amyloid plaque formation
92
Correspondence between in vivo 11 C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques
93
Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy
94
Distribution of amyloid plaques in the cerebellum in Alzheimer's disease
95
β-Amyloid(1–40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield
96
[ 18 F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies
97
Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease
98
Microglial activation in early stages of amyloid β protein deposition
99
White matter alterations following thromboembolic stroke: a β-amyloid precursor protein immunocytochemical study in rats
100
Intrasellar amyloid tumor
101
Heparan sulfate proteoglycan expression in cerebrovascular amyloid β deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains